endogene.bio has been named the winner of the 2026 Hello Tomorrow Challenge, one of the world's leading deep tech competitions. Selected from more than 4,800 applicants and 100 finalists, the company was awarded a €100,000 prize in recognition of its work advancing uterine health through biological data generation.
About endogene.bio
endogene.bio generates high-resolution biological data from menstrual blood, unlocking a previously inaccessible layer of human uterine biology. Our platform enables disease understanding, patient stratification, and therapeutic discovery across uterine health.
